Scotia Capital’s Reunion Neuroscience Inc. Common Shares REUN Stock Holding History

Scotia Capital’s Portfolio REUN Stock Details REUN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-9,876	Closed	-$40K	–	845
2022 Q2	$40K	Buy	9,876 +175	+2%	+$874	﹤0.01%	787
2022 Q1	$65K	Sell	9,701 -250	-3%	-$2.08K	﹤0.01%	852
2021 Q4	$120K	Buy	9,951 +402	+4%	+$8.61K	﹤0.01%	832
2021 Q3	$219K	Buy	+9,549	New	+$240K	﹤0.01%	780

Other funds holding REUN

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

OMC

Oasis Management Company Grand Cayman, Cayman Islands $1.88B AUM 54.21% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

OPOWM

One Plus One Wealth Management Jupiter, Florida $232M AUM 28.06% 1-Year Est. Return

VCM

Vivaldi Capital Management Chicago, Illinois $723M AUM 30.89% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

CAM

Cidel Asset Management Toronto, Ontario, Ontario, Canada $2.08B AUM 24.89% 1-Year Est. Return

CIBC World Market Toronto, Ontario, Canada $62.3B AUM 44.64% 1-Year Est. Return

HSA

HBK Sorce Advisory Erie, Pennsylvania $5.27B AUM 19.34% 1-Year Est. Return

Scotia Capital's REUN Position: Q3 2022 in Review

Scotia Capital sold out of Reunion Neuroscience Inc. Common Shares (REUN) in Q3 2022, closing a stake of 9,876 shares — an estimated $40K sold.

Scotia Capital first reported a position in REUN in Q3 2021 and held it in 4 quarters. The position peaked at $219K in Q3 2021. 27 funds tracked by Wall St. Rank hold REUN as of Q3 2022.

Scotia Capital reported no remaining Reunion Neuroscience Inc. Common Shares position as of Q3 2022 after selling out during the quarter.
Scotia Capital sold 9,876 Reunion Neuroscience Inc. Common Shares shares in Q3 2022, an estimated $40K.
Scotia Capital first reported a position in Reunion Neuroscience Inc. Common Shares in Q3 2021 and held it in 4 quarters.
Scotia Capital's Reunion Neuroscience Inc. Common Shares position peaked at $219K in Q3 2021.
27 funds tracked by Wall St. Rank held Reunion Neuroscience Inc. Common Shares as of Q3 2022.

Based on Scotia Capital's 13F filing for Q3 2022, filed 10 Nov 2022.